HEALWELL AI and WELL Health Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

Core Insights - HEALWELL AI Inc. and WELL Health Technologies Corp. have launched WELLTRUST™, a platform designed for secure, consent-driven patient identification for clinical research within WELL-operated clinics in Canada [1][10]. Company Overview - HEALWELL AI focuses on preventative care through healthcare artificial intelligence, aiming to improve healthcare outcomes by early disease detection and clinical decision support systems [7]. - WELL Health Technologies aims to empower healthcare providers through technology, operating over 240 clinics in Canada and serving more than 43,000 healthcare providers across North America [8]. Platform Features - WELLTRUST accelerates clinical research recruitment by allowing patients to consent to future outreach for clinical trials, combining WELL's clinical footprint with HEALWELL's AI capabilities [2][10]. - The platform provides a privacy-preserving infrastructure that enables ethical patient identification and research acceleration while allowing patients to opt-out if they choose [2][11]. - WELLTRUST includes a robust governance and compliance framework to meet Canadian privacy standards, facilitating partnerships with pharmaceutical sponsors and research organizations [11]. Leadership Commentary - Dr. Alexander Dobranowski from HEALWELL emphasized the platform's commitment to responsible AI in healthcare, aiming to enhance patient access to innovations while maintaining privacy [3]. - Dr. Michael Frankel from WELL highlighted the importance of technology in improving healthcare outcomes and empowering patients to participate in research safely [5].